Related references
Note: Only part of the references are listed.EZR-ROS1 fusion renal cell carcinoma mimicking urothelial carcinoma: report of a previously undescribed gene fusion in renal cell carcinoma
Antic Tatjana et al.
VIRCHOWS ARCHIV (2022)
The rapidly evolving landscape of novel targeted therapies in advanced non-small cell lung cancer
Barbara Melosky et al.
LUNG CANCER (2021)
GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma types
Philipp Sievers et al.
ACTA NEUROPATHOLOGICA (2021)
Case Report: Detection of Double ROS1 Translocations, SDC4-ROS1 and ROS1-GK, in a Lung Adenocarcinoma Patient and Response to Crizotinib
Long Xu et al.
FRONTIERS IN MEDICINE (2021)
Association of Subjective Cognitive Decline with Risk of Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis of Prospective Longitudinal Studies
X-T Wang et al.
JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE (2021)
ROS1-rearranged Non-small-cell Lung Cancer is Associated With a High Rate of Venous Thromboembolism: Analysis From a Phase II, Prospective, Multicenter, Two-arms Trial (METROS)
Rita Chiari et al.
CLINICAL LUNG CANCER (2020)
Evidence of NTRK1 Fusion as Resistance Mechanism to EGFR TKI in EGFR plus NSCLC: Results From a Large-Scale Survey of NTRK1 Fusions in Chinese Patients With Lung Cancer
Hui Xia et al.
CLINICAL LUNG CANCER (2020)
ALK and ROS1 rearrangement tested by ARMS-PCR in non-small-cell lung cancer patients via cytology specimens: The experience of Shanghai Pulmonary Hospital
Ziyang Cao et al.
DIAGNOSTIC CYTOPATHOLOGY (2020)
First-line crizotinib versus platinum-pemetrexed chemotherapy in patients with advanced ROS1-rearranged non-small-cell lung cancer
Lan Shen et al.
CANCER MEDICINE (2020)
Glioblastomas harboring gene fusions detected by next-generation sequencing
Ha Young Woo et al.
BRAIN TUMOR PATHOLOGY (2020)
Molecular and clinicopathological characteristics ofROS1-rearranged non-small-cell lung cancers identified by next-generation sequencing
Meiying Cui et al.
MOLECULAR ONCOLOGY (2020)
Performance of Oncomine Fusion Transcript kit for formalin-fixed, paraffin-embedded lung cancer specimens
Kazuko Sakai et al.
CANCER SCIENCE (2019)
High feasibility of cytological specimens for detection of ROS1 fusion by reverse transcriptase PCR in Chinese patients with advanced non-small-cell lung cancer
Limin Zhang et al.
ONCOTARGETS AND THERAPY (2019)
Response to crizotinib in a patient with metastatic lung spindle cell carcinoma harboring TPM3-ROS1 fusion
Cun-Liang Cai et al.
CHINESE MEDICAL JOURNAL (2019)
Clinicopathological features and clinical efficacy of crizotinib in Chinese patients with ROS1-positive non-small cell lung cancer
You-Cai Zhu et al.
ONCOLOGY LETTERS (2019)
Concurrent ROS1 gene rearrangement and KRAS mutation in lung adenocarcinoma: A case report and literature review
You-cai Zhu et al.
THORACIC CANCER (2018)
High performance of targeted next generation sequencing on variance detection in clinical tumor specimens in comparison with current conventional methods
Dan Su et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Circulating Tumor DNA Mutation Profiling by Targeted Next Generation Sequencing Provides Guidance for Personalized Treatments in Multiple Cancer Types
Yongqian Shu et al.
SCIENTIFIC REPORTS (2017)
Molecular Pathways: ROS1 Fusion Proteins in Cancer
Kurtis D. Davies et al.
CLINICAL CANCER RESEARCH (2013)
CD74-ROS1 fusion transcripts in resected non-small cell lung carcinoma
Shun Matsuura et al.
ONCOLOGY REPORTS (2013)
Identification of KIF5B-RET and GOPC-ROS1 Fusions in Lung Adenocarcinomas through a Comprehensive mRNA-Based Screen for Tyrosine Kinase Fusions
Yoshiyuki Suehara et al.
CLINICAL CANCER RESEARCH (2012)
The Dual ALK/EGFR Inhibitor AP26113 Also Potently Inhibits Activated and Gatekeeper Mutant Forms of ROS1
R. Anjum et al.
EUROPEAN JOURNAL OF CANCER (2012)
Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis
Alice T. Shaw et al.
LANCET ONCOLOGY (2011)
Chromosome 3 Anomalies Investigated by Genome Wide SNP Analysis of Benign, Low Malignant Potential and Low Grade Ovarian Serous Tumours
Ashley H. Birch et al.
PLOS ONE (2011)
The UCSC Table Browser data retrieval tool
D Karolchik et al.
NUCLEIC ACIDS RESEARCH (2004)
Fusion of FIG to the receptor tyrosine kinase ROS in a glioblastoma with an interstitial del(6)(q21q21)
A Charest et al.
GENES CHROMOSOMES & CANCER (2003)
Share Paper
